CAS 5382-16-1 | 4-Hydroxypiperidine | CAS Number 5382-16-1

200,000+ products from a single source!

sales@angenechem.com

Product Categories

Home > Other Building Blocks > 5382-16-1

5382-16-1 | 4-Hydroxypiperidine

CAS No: 5382-16-1 Catalog No: AG00342I MDL No:MFCD00005999

Product Description

Catalog Number:

AG00342I

Chemical Name:

4-Hydroxypiperidine

CAS Number:

5382-16-1

Molecular Formula:

C5H11NO

Molecular Weight:

101.1469

MDL Number:

MFCD00005999

IUPAC Name:

piperidin-4-ol

InChI:

InChI=1S/C5H11NO/c7-5-1-3-6-4-2-5/h5-7H,1-4H2

InChI Key:

HDOWRFHMPULYOA-UHFFFAOYSA-N

SMILES:

OC1CCNCC1

EC Number:

226-373-1

UNII:

KC61EA060X

NSC Number:

62083

Properties

Complexity:

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

101.084g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

101.149g/mol

Monoisotopic Mass:

101.084g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

32.3A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

-0.3

Literature

Title	Journal
Synthesis of novel IP agonists via N-aminoethyl cyclic amines prepared by decarboxylative ring-opening reactions.	Molecules (Basel, Switzerland) 20120131
4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium 2-(2-phenyl-eth-yl)benzoate.	Acta crystallographica. Section E, Structure reports online 20110701
A Baeyer-Villiger oxidation specifically catalyzed by human flavin-containing monooxygenase 5.	Drug metabolism and disposition: the biological fate of chemicals 20110101
2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.	Bioorganic & medicinal chemistry letters 20110101
Investigation of 4-piperidinols as novel H3 antagonists.	Bioorganic & medicinal chemistry letters 20101101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.	Bioorganic & medicinal chemistry letters 20101101
4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium maleate maleic acid solvate.	Acta crystallographica. Section E, Structure reports online 20100801
The spectroscopic (FT-IR, FT-IR gas phase, FT-Raman and UV) and NBO analysis of 4-Hydroxypiperidine by density functional method.	Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100301
4-(4-Chloro-phen-yl)-1-[3-(4-fluoro-benzo-yl)prop-yl]-4-hydroxy-piperidin-1-ium 2,4,6-trinitro-phenolate (haloperidol picrate).	Acta crystallographica. Section E, Structure reports online 20091001
Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.	Bioorganic & medicinal chemistry 20080815
Erratum: Poly[μ(2)-chlorido-nona-methyl-μ(3)-nitrato-tritin(IV)]. Corrigendum.	Acta crystallographica. Section E, Structure reports online 20080701
CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.	Bioorganic & medicinal chemistry letters 20070401
Organosilicon-containing thiazole derivatives as potential lipoxygenase inhibitors and anti-inflammatory agents.	Bioinorganic chemistry and applications 20070101
Improved synthesis and radiolabeling of [11C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET.	Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20060201
Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.	Journal of immunology (Baltimore, Md. : 1950) 20030215
The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.	European journal of medicinal chemistry 20020601
New mu-opioid receptor agonists with phenoxyacetic acid moiety.	Chemical & pharmaceutical bulletin 20020201
Cytotoxic and anticancer properties of some 4-aryl-3-arylcarbonyl-1-ethyl-4-piperidinols and related compounds.	Die Pharmazie 20010501